2 Bridge is the go-to company for those venturing into life sciences. Together with investors, founders, and startups, we are devoted to advancing healthcare product development and company building.
To achieve success, we assemble and guide multi-disciplinary teams of experts tailored to the project needs. The unique advantages of our cross-functional 2 Bridge teams include speed & efficiency, end-to-end expertise, transparency & oversight, and a dedicated focus on your business goals.
2 Bridge, the Ecosystem to build your life sciences company.
a-ULaB is a laboratory specialized in the identification of asbestos fibres presents in bulk samples and air samples. Established in 2011, this spin-off of the Université libre de Bruxelles (ULB) and of the Erasmus Hospital is the result of the medical profession and the sector of construction.
AbolerIS Pharma, the Immune System under Control.
AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance and preserves useful immune responses in inflammatory, autoimmune and degenerative diseases
Agricells supporte la transition écologique et participe à l'écosystème en développant des biosolutions
Apaxen is a preclinical stage biotechnology company developing a unique class of anti-inflammatory therapeutics with a primary focus on pulmonary arterial hypertension (PAH).
Aquilon Pharmaceuticals develops innovation inhaled formulations for the treatment of asthma and COPD.
We are Ardena, a fully integrated Contract Development & Manufacturing Organization (CDMO) with a core focus on bringing molecules to the clinics.
We are operate from six state-of-the-art, purpose-built facilities across Western and Northern Europe.
We service a broad and global customer base including prominent blue-chip companies. We have an outstanding quality and regulatory track-record, verified by full GMP and GLP compliance.
Atryon is a strategy and management consultancy firm expert in LifeSciences Industry. We help our clients to gear their projects from strategy to the results, with combined business, scientific, and industrial skills. We hold a strong expertise on defining, implementing and optimizing operating business models, focusing on continuous improvement of performance, quality and compliance.
Barré SA is a specialized supplier of the Pharma and Biopharma production sites. The company is active in the Design, Production, Installation and Maintenance of Clean Piping and Air Processing equipment. Barré also designs and produces a large variety of special inox steel pieces for FDA-certified customers. Next to those core activities, Barré offers various services in Mechanical, Electrical, Pneumatic and Automation Engineering.
BePharBel Manufacturing produces, on pilot project or industrial scale, pharmaceutical and para-pharmaceutical products in a range of galenic forms: Liquid forms (syrups, nasal sprays, sterile vials), Dry forms (tablets, granules, capsules, sterile powders), Pasty forms (creams, ...)
Bioxodes is a biotech start-up specialized in the development of novel therapeutics using molecules from nature dedicated to prevent thrombosis and inflammatory processes.
Calysta est un cabinet de conseils en propriété intellectuelle (PI) d’un style nouveau, résolument moderne.
Calysta se positionne comme un acteur incontournable de la propriété intellectuelle, riche de talents les plus expérimentés et passionnés, ayant pour ambition de dépasser vos attentes. Nos conseils ne gèrent pas seulement avec minutie la protection et la défense de vos actifs de propriété intellectuelle,ils sont avant tout désireux de comprendre le fonctionnement et la stratégie de votre entreprise, afin d’adapter nos services à vos besoins réels. Nos experts sont nos ambassadeurs, avec des profils et des compétences à la fois différents et complémentaires.
Cancer State Therapeutics’s mission is to discover and develop first-in-class small molecule therapeutics for unmet needs in oncology
We are a global leader in providing integrated services, superior drug delivery technologies and manufacturing solutions to help life science innovators develop and launch successful pharmaceuticals, biologics and consumer health products. We have built an advanced range of technologies and capabilities and are dedicated to enabling a better and faster customer journey from product development to patient.
Centre de formation de l’industrie chimique et (bio)pharmaceutique
Our mission is to be the global partner of choice for biopharmaceutical companies seeking precision medicine solutions to help ensure a healthier future for us all
The CMMI is an integrated preclinical imaging facility which provides services and training for academic and industrial partners. Our multidisciplinary team offers a wide range of services, covering the entire workflow: sample preparation, image acquisition and analysis.
The CMMI was established with the financial support of the European Union and the Walloon Region (FEDER program) and is located in the BioPark Charleroi Brussels South, a site which hosts two academic institutes and several companies active in the field of life sciences.
The Centre Hospitalier Universitaire Ambroise Paré is the general public hospital of the City of Mons and its district. It is part of the intermunicipal Centre Hospitalier Universitaire et Psychiatrique de Mons-Borinage and offers a wide range of general and specialised hospital care and services for both adults and children.
Saint-Pierre University Hospital is a local public hospital, offering high quality care accessible to all, regardless of origin, philosophical or religious beliefs or patients' social condition. In this context, we take up the challenges of public health on a daily basis while declining our academic character through active involvement in teaching and research.
Saint-Pierre University Hospital is part of the Centre Hospitalier Universitaire de Bruxelles (CHUB), which brings together the public and university hospitals in Brussels (CHU Brugmann, HUDERF, Institut Jules Bordet).
Le Centre Hospitalier Universitaire de Charleroi est un hôpital public géré par l'ISPPC (Intercommunale de Santé Publique du Pays de Charleroi).
Dans la perspective régionale de valorisation, de simplification et d’optimisation de l’offre de service aux entrepreneurs pour le développement économique de la Wallonie et dans la foulée de la dynamique initiée par le plan CATCH, Charleroi Entreprendre est le fruit de l’union des équipes d'animation économique du CEEI Héraclès, d'Igretec et du Switch coworking.
Within the CHC network, Clinique Saint-Joseph is the reference point for heavy adult services: oncology, radiotherapy, cardiac coronary angiography, heavy abdominal surgery, neurosurgery, orthopedics, interventional imaging, PET-scan, MRI, Stroke Unit....
The clinic has 335 beds and employs about a thousand people (staff and freelancers).
UCL Namur University Hospital and its Integrated Network of Care and Services are the result of the merger, in 2016, of the Dinant Godinne | UCL Namur University Hospital and the Sainte-Elisabeth Clinic and Maternity Hospital. Located in the province of Namur, the new entity is spread over the hospital sites of Dinant, Godinne and Sainte-Elisabeth. In addition to hospital activities, the UCL Namur University Hospital has facilities for the accommodation of the elderly and early childhood care.
With more than 4,500 employees (including 500 doctors), the UCL Namur University Hospital offers a complete range of care and services to its patients.
The Centre Hospitalier Universitaire de Charleroi is a public hospital managed by the ISPPC (Intercommunale de Santé Publique du Pays de Charleroi).
The mission of the CHU: to offer quality care and hospitality to all.
Established in the north of Charleroi, Clinique Notre-Dame de Grâce has chosen to remain a friendly hospital close to people where patients, both in their medical and personal dimensions, are at the heart of its concerns.
Clinique Saint-Pierre Ottignies is a regional reference hospital centre whose mission is to take care of patients who entrust their health to it. They are at the centre of all our attention and at the basis of all investments and recruitments, as well as of our permanent concern for improvement and our desire to transmit this vocation.
CoCEPTIO is a business and technical expert thanks to its solid-experienced associates, that offers a flexible project approach, more integrated and pragmatic.
Anxious to respond to its customers’ new challenges, CoCEPTIO is placed as a true partner for the conception of their industrial projects, from the project definition or the building-up of their master plan to the follow-up of the implementation and the commissioning & qualification/validation of the installations. CoCEPTIO will also assist its customers in the elaboration of maintenance plan or in the quality insurance approach (setting-up of a “Validation Master Plan”, various procedures, …).
We are mainly active in the Life Science sector (Pharma, Biotechnology, …), hospitals (Pharmacy, Stem Cells, Operating area, Ultra-protected ICU, …), chemicals/petrochemicals and other specific industries (food processing industry, electronics, …) always with the will to intervene in advanced/leading/High-tech sectors where rapid and accurate intervention are essential.
Our mission is to design and build multi-technical installations (based on the customer’s expectations) with a result-oriented commitment (quality, budget & planning). Our customers can than stay focus on their job and be convinced that the proposed technical solution is the most reliable and well-adapted to their specific application.
Le CQHN (1975) est un centre de formations en Management de la Qualité (notre spécialité dans tous secteurs), Sécurité, Environnement, Responsabilité Sociétale & Energie, aux Outils (Management des Systèmes – Stratégiques – Statistiques – Risques – Gestion de projet - Qualité totale), en Validation - Qualification & Réglementation (Secteurs LifeSciences), en Développement Personnel, en Communication ainsi qu'en Achats-Logistique.
Provides Engineering Services and GMP/Validation Consulting Services in the pharmaceutical and biotechnology industries (or based on similar technologies): aseptic production areas, hospital pharmacy, controlled environments or critical and ultra-pure utilities, and specialized laboratories with high level of constraints: clean rooms, biological or radioactivity containment, climatic chambers, animal facilities and disinfection systems.
Endo Tools Therapeutics (ETT) is a privately held medical device company in Gosselies, Belgium. ETT is dedicated to the development of innovative devices providing new means of therapeutic interventions for gastroenterologists.
It is a spin-off from Université libre de Bruxelles, based on a collaboration between the engineers of the engineering school and the gastroenterologists from Erasme Hospital.
EPICS Therapeutics is a new and rapidly progressing drug discovery company based in Belgium. Current research focus is on the targeting of epigenetic mechanisms involved in cancer development. Our business objectives consist in the discovery and development of novel clinical agents targeting serious unmet medical needs in oncology.
The hospital is located on the Erasmus Faculty Hospital Campus, which includes the Faculty of Medicine, the Faculty of Motor Sciences and the School of Public Health. The main areas of excellence of Erasmus Hospital are : The Neurosciences, Psychiatry, Medical and surgical, gastroenterology, Cardiovascular and pulmonary sectors, Gynecology-Obstetrics. The Genetics, Transplantation and Intensive Care.
The CRO with more than 20 years of expertise on GPCR screening
Exothera is a CDMO delivering customized process development and GMP production services for viral vectors
Fund+ is an open-ended Fund for long term equity investment in innovative Life Sciences companies with a focus on Belgium. We want to create sustainable shareholders value, contribute to the development of a leadership position in the Life Sciences sector and generate a tangible, beneficial societal impact.
GENFLOW is dedicated to the development and commercialization of novel therapeutics targeting aging in dogs and humans. Aging is not a natural fatality. There is no rationale for a limited lifespan. Aging can now be considered as a risk factor that we can treat. By treating aging, we believe that GENFLOW can contribute to decrease healthcare costs and lessen the emotional and societal burden that comes with an aging population.
Spin-off company of the Université Libre de Bruxelles. The mission of the company is to develop novel therapeutic approaches for solid cancers and inflammatory diseases. The main focus is presently on small molecules targeting selected G protein-coupled receptors.
/
GEVERS, an intellectual property firm, is located in the heart of Europe with 6 offices in Belgium (Brussels/Diegem, Antwerp/Berchem, Ghent, Hasselt, Liège and Mont-Saint-Guibert) and forms a group with GEVERS & ORES with 2 offices in France (Paris and Toulouse). The group provides a range of advice and services for the creation, development, management, protection and exploitation of Intellectual Property (IP) rights.
The 360° approach to IP strategy explains the value and necessity of creating and maintaining IP rights within an organisation: identify, protect, monetise and enforce.
Products/Services
GEVERS offers its clients the opportunity to develop and protect their innovations through intellectual property rights, including patents, trademarks, designs, domain names, copyrights, trade secrets, technology transfers, or through tax benefits. With its expertise and practical experience in various technical fields, GEVERS is involved in innovation in many sectors, such as the chemical industry, the automotive industry, the pharmaceutical industry, energy, biotechnology, nanotechnology, polymer sector, electronics, agriculture and more…
An innovative response to the challenge of financing global health research and development.
At GHO Capital we understand healthcare trends and opportunities which enables us to identify, invest in and build fast-growing, dynamic businesses. With attractive fundamentals and a shift in market dynamics, we recognise the significant potential in European healthcare and have prioritised our focus on high growth segments.
The Grand Hôpital de Charleroi now includes 6 hospital sites, 4 consultation centres and various support services. In all, it represents more than 4,500 people in all specialties and professions. It is the second largest employer in Charleroi.
The Grand Hôpital de Charleroi is one of the largest private hospitals in Wallonia. Its state-of-the-art hospital activities and the competence of its specialists make it a complete hospital. It offers optimal and quality care for a wide range of pathologies and traumas.
Actif depuis plusieurs années dans le monde de la consultance RH, habeas offre une gamme de services spécialisés dans le recrutement et la sélection, l'évaluation de personnes, le coaching et l'outplacement.
habeas a fait le choix de la polyvalence et se positionne comme un généraliste, tant en termes de profils recrutés ou évalués que de secteurs et projets réalisés.
La clientèle de habeas couvre de nombreux secteurs : privé en national et à l’international, public, parapublic… A ce jour, près de 900 clients, très majoritairement des PME, ont déjà fait confiance à habeas.
Les profils gérés concernent des fonctions de généralistes comme d’experts, à différents niveaux de l’organigramme (employés spécialisés, cadres, management, CEO…) et dans des domaines aussi variés que : production, maintenance, technique (engineering, R&D…), logistique, sécurité, qualité, finances, RH, achats, sales, marketing...
Haute Ecole Louvain en Hainaut (Helha)
Heart Kinetics develops a cardiac remote patient monitoring system based on cutting-edge ballisto-seismocardiography for the prevention of heart failure.
HeLSci, ULB Center for Continuous Education in Health and Life Sciences
Your expert in critical environment control - HeX Control operates in critical environments where contamination management is a natural requirement (clean rooms and controlled environments) as well as in environments with non-specific pollution (offices, buildings open to the public, housing, etc)
Centre Hospitalier Jolimont has more than 125 years of expertise and state-of-the-art techniques, with qualified staff and heavy services, for multidisciplinary patient care. He is forward-looking and constantly looking for new features and improvements.
Hussard is a Data Privacy Consultancy specialised in Healthcare, Life Sciences and Clinical Trials. Our team comprises seasoned lawyers certified in GDPR and Good Clinical Practice (GCP). Our mission is to provide help, support, advice and guidance. We focus exclusively on Healthcare, Life Sciences and Clinical Trials, and have tailored our compliance process for that segment. We also act as EU Legal Representative for biopharma companies not established in the European Union. Our partners choose us because of our integrity, responsiveness and high expertise.
ICOSA est un cabinet de Propriété Intellectuelle principalement dédié au secteur de la Santé, avec une expertise complémentaire en Agroalimentaire et Environnement.
Nous participons à la création d’actifs de propriété intellectuelle qui assurent à nos clients la protection efficace de leurs innovations.
Nous consacrons nos compétences techniques, juridiques et commerciales au développement de stratégies de propriété intellectuelle alignées sur la stratégie de l’entreprise.
L’équipe ICOSA comprend des conseils en brevets titulaires d’un doctorat et/ou d’un diplôme d’ingénieur. Grâce à son expertise scientifique et son expertise technique de haut niveau, l’équipe d’ICOSA maîtrise les enjeux de Propriété Intellectuelle propres à chacun de nos clients.
Nous intervenons à toutes les étapes de la protection de la Propriété Intellectuelle : dépôt de brevets et de marques, élaboration de stratégies de Propriété Industrielle, émission d’avis juridiques sur la brevetabilité ou la liberté d’exploitation et évaluation financière de la valeur des portefeuilles d’actifs de Propriété Intellectuelle.
Idealis Consulting is a team that designs, develops, integrates and supports your ODOO solutions in order to make our customers more productive, responsive and profitable.
Our mission is to support your growth and guarantee your digital transformation thanks to Odoo. We offer an adequate solution for every business problem you have to face. Our mission is to get you close to where your Ideal IS. Our consultants will accompany you throughout your projects by offering you a ERP solution adapted to your needs during all your projects.
We help you whatever your sector. Moreover, our consultants have developed vertical solutions that meet the specificities of certain sectors. Avoid the cost of extreme customization and benefit from a quick implementation like Smart Biotech, Business Center, E-Commerce, Talent Management HR, Food Delivery and much more to come.
Intercommunale pour la gestion et la réalisation d'études techniques et économiques.
ImmunXperts offers services to support your drug development process, be it by mitigating risks through immunogenicity assessment or by saving time and money through custom assay development.
InhaTarget Therapeutics develops innovative and targeted dry powders for inhalation (DPI) that aim to improve the treatment of severe and/or chronic respiratory diseases.
The Innovation Fund sa/nv invests in innovative startups and companies active in the field of chemistry and life sciences.
Research at IMI focuses on enhancing basic knowledge of the cross-talk between innate and adaptive immune responses in order to set up new immunotherapeutic strategies and assess their effectiveness. The IMI conducts research in four areas of medical immunology: the development of the immune system, viral infections, vaccinology and transplantation.
Institute of Molecular Biology and Medecine (IBMM)
L’IPG est spécialisé dans le diagnostic médical en matière d’Anatomopathologie, de Génétique, de Biologie Moléculaire & Cellulaire et Microbiologie Moléculaire.
IRE or National Institute of Radioelements is a public utility foundation, whose main activity is the production of radioisotopes for diagnostic and therapeutic applications in the field of nuclear medicine. IRE is the world leader in the production of Molybdenum-99, the "parent" isotope of metastable Technetium-99m, and the most widely used in nuclear medicine for many examinations (heart, bones, lungs, thyroid , the brain, the kidneys etc…). IRE, beyond its production activities, contributes through its IRE Lab division to the protection and monitoring of the environment through its services for measuring radioactivity in various samples, radiological characterization of waste and contaminated elements and consultancy and technical assistance in the radiological and nuclear fields. IRE ELiT, the innovation subsidiary of IRE, is a radiopharmaceutical company founded in 2010 to fully develop radiopharmaceuticals used in molecular imaging and therapy. IRE ELiT works closely with its clients in a «test & learn» spirit as well as with globally recognized universities and research centers. Today, IRE ELiT is one of only two global suppliers of germanium-68 (Ge-68)/gallium-68 (Ga-68) generators approved for use as a drug in Europe and as an active pharmaceutical ingredient (API) in the U.S.
iTeos Therapeutics is targeting the tumor microenvironment to enhance the effectiveness of immune cells at eradicating cancer.
Introducing Jansen Cleanrooms & Labs, a division of Group Jansen, specializes in the design and build of clean environments, exceeding industry with its architectural and technical expertise. Their integrated approach to project management ensures seamless progression from initial concept to final implementation, reinforcing our commitment to quality and excellence in every phase.
Their integrated project management approach ensures smooth progression from concept to completion, emphasizing quality and excellence at every step.
Jansen Cleanrooms & Labs offers comprehensive in-house services, collaborating closely with clients to deliver tailored solutions. From concept to commissioning, their expertise spans architectural craftsmanship, HVAC systems, automation, and more. Specializing in cleanroom and lab solutions, they cater to critical sectors such as Healthtech, high-tech, aerospace & defense, and Chemtech, meeting rigorous regulatory standards for precision and control.
Innovation powerhouse
Janssen in Belgium has been focusing on research and development for more than 60 years. The campus in Belgium has been instrumental in the discovery and development of a new generation of tuberculosis, HIV/AIDS, cancer, infectious diseases and neurological drugs. It was here in Beerse that the first FDA-approved tuberculosis drug in 40 years was discovered and developed.
Johnson & Johnson is now the world's largest and most important healthcare company. Every day, more than 130,000 employees around the world combine heart, science and ingenuity to fundamentally change the trajectory of health for humanity.
Kokuma is a cutting-edge beauty tech company revolutionizing skincare through AI. By deeply understanding skin cell biology and melanin synthesis, we've discovered unique ingredients that naturally influence skin tone. Our mission is to empower individuals to achieve their desired complexion.
The Laboratoire de biotechnologie végétale (LBV) seeks to understand the molecular mechanisms that control vegetable development and its interactions with the environment.
Founded in 1999, Laporte is a Canadian engineering firm specializing in plant design in the pharmaceutical, biotechnology, agrifood, and bioindustrial sectors. We employ almost 400 engineers, technicians and experts who provide services with a focus on process design, buildings and infrastructure, filling and packaging, automation, and regulatory compliance.
Laporte has been executing mandates in Europe since 2006 and has inaugurated Laporte Euro in 2010 for offering a complete range of services in Europe. Laporte Euro has offices in Nantes, Paris, Lyon, Pau, Genève, Montreux and since 2021 in Belgium.
The recognition Laporte has gained in only 22 years, and the significant business volume stemming from repeat contracts from clients demonstrate the quality of the services that Laporte can provide to European firms, through its subsidiaries.
LSB – La salle blanche conçoit, réalise et installe des salles propres, des zones à atmosphère contrôlée et du mobilier de labo pour l’industrie pharmaceutique, l’hospitalier et la recherche depuis plus de 30 ans.Créateurs d’innovations technologiques, la salle blanche devient un équipement connecté et communiquant dans une structure flexible, modulaire et conforme aux plus strictes exigences de qualité.
LSB a développé la solution BioGuard : une solution intégrée et intelligente dédiée à l’activité chirurgie.
Lys Medical develops an endoscopic decision-aid device for airway physicians.
Minoryx Therapeutics is a clinical stage biotech company leading the development of new therapies for X-ALD and other Orphan CNS diseases, a group of rare diseases of genetic origin with a high unmet medical need. The company’s leading program, a differentiated PPAR gamma agonist (MIN-102), is a candidate for X-linked Adrenoleukodystrophy that has successfully completed phase 1 clinical trials and is now in a pivotal phase 2/3 trial. Minoryx harnesses its unique mechanism of action for potential use in X-ALD, a genetic disease characterized by progressive neurological deterioration with no available pharmacological treatment.
Minoryx is also working on expanding the use of MIN-102 into other CNS diseases.
Ncardia is a stem cell drug discovery & development company operating worldwide with facilities and offices in Belgium, the Netherlands, and the USA. Ncardia is built on the belief and trust that stem technology will help to get better medicines to patients faster. The goal of the company is to be the supportive and trusted partner for scientists operating in the hiPSC drug discovery and development space including cardiovascular and neural safety and efficacy studies.
NeuVasQ Biotechnologies develops pharmaceuticals to restore blood-brain barrier function in neurological disorders.
New Science Ventures, LLC (NSV) is a leading venture capital firm focused on building companies that leverage breakthrough science to create extraordinary value. NSV invests in companies using science-based innovations to address market needs in Life Sciences (pharmaceuticals, biologics, medical devices, and diagnostics) and Information Technology (e.g., high-performance semiconductors, cellular infrastructure, sensor networks, enterprise software, and storage) sectors.
Newton Biocapital is a Venture Capital Fund incorporated in Belgium, focused on financing biotech and life science projects in the "core of Europe" (B, NL, D, F) and Japan for the prevention and treatment of chronic diseases.
Novasep is a leading provider of services in the field of molecule production and purification for the life science and chemical industries, based on an unrivalled pool of specialized technologies.
Our unique business model addresses our customers’ manufacturing strategies, and is based on 2 sets of offerings for 7 markets.
With 1,200 employees, Novasep is established in Europe, Asia and North America and is constantly expanding its presence to better serve its customers.
Thermo Fisher has completed the acquisition of Novasep’s viral vector manufacturing business in Belgium. Novasep’s viral vector business is an excellent strategic fit as Thermo Fisher continues to expand its capabilities for cell and gene vaccines and therapies globally.
At OncoDNA we strive to help cancer patients. OncoDNA offers solutions combining the most relevant molecular technologies in order to provide a comprehensive characterization of the patient’s cancer, hence supporting oncologists in their treatment and follow-up decisions.
At Ooho, they excel in providing top-tier marketing and business development strategies that consistently deliver outstanding results.
Their distinctive approach combines modern operational marketing with a deep scientific understanding, always going the extra mile to set themselves apart.
Whether it's refining digital marketing tactics, launching a new product or feature, developing new channels, or integrating cutting-edge business development tools, Ooho ensures that their clients experience a significant boost in lead generation and overall marketing impact.
Paracrine Biologicals develops therapeutic exosomes from mesenchymal stem cells to treat rare diseases and auto-immune diseases.
PharmaLex is one of the largest specialized providers of Development Consulting, Regulatory Affairs, Quality Management & Compliance and Pharmacovigilance, Epidemiology & Risk Management worldwide. Our GLOCAL (GLObal reach and loCAL presence) teams of experts can take you through early strategic planning activities and non-clinical requirements to clinical development, through regulatory submission processes and finally guide you to market approval and product maintenance post-launch activities.
Pharmaplan is an engineering company entirely dedicated to the pharmaceutical and biotech industries. In this highly regulated environment, we bring to our clients our pharma and biotech expertise and a proven engineering model. Within TTP Group, we operate from 27 offices in Belgium, France, Germany, Switzerland, Austria, and India, with over 1,000 specialists.
We act as general design contractor (‘Maître d’oeuvre’) or consultants for the execution of various projects: revamping, construction, capacity increase, optimization, regulatory compliance of laboratories and/or production units. Our core business is the production process and the regulatory expertise. Our services cover the complete project lifecycle, from strategy definition up to the complete execution and qualification, for all technical disciplines: project management, process, HVAC, clean and black utilities, electricity, process and building automation, cleanroom, building.
QbD offers worldwide expertise and solutions in the field of Quality Management, Validation, Project Management & Support and Regulatory Affairs
Quality Assistance is a leading European Contract Research Organisation providing the pharmaceutical industry with all the analytical services required by EMA and FDA regulations for the development and marketing of innovative human medicinal products.
Inaugurated in 1986, Queen Fabiola Children's University Hospital is the only Belgian university hospital entirely reserved for children's medicine : all is conceived for them and for their parents.
From birth to adolescence, the children receive there the most complete care.
We are a Belgian company dedicated to the discovery of novel cancer medicines. We apply state-of-the-art novel technology to treat patients with solid tumors
Cliniques universitaires Saint-Luc is the largest hospital of Brussels, with 5800 employees and more than 900 beds. Beyond providing optimal patient care, Saint-Luc partners with the Université Catholique de Louvain (UCLouvain) in activities centered on research, innovation and teaching.
Saint-Luc provides reference care and treat serious, rare or complex diseases of patients in Belgium and abroad.
Sambrinvest is the financial partner of SMEs in the Charleroi Sud-Hainaut region.
La création de Seqalis™ représente une étape importante dans ses 19 ans d'histoire. Ce nom incarne les concepts clés de Service, d'Assurance Qualité et de Sciences de la Vie. Incontestablement, il souligne la détermination de Bio.be à renforcer son expertise unique en Anatomopathologie, Cytogénétique et Biologie Moléculaire ainsi que son ambition de devenir un partenaire important de l'industrie pharmaceutique, des biotechs et des universités.
SFPI-FPIM is the federal public holding company, which fulfils a dual function. It not only acts as an investment company, but also as a government holding company. The investments as a public holding company are done in consultation with the government. In addition to the public holding function, SFPI-FPIM can also acquire equity in companies at the explicit request of the federal government. These are the so-called delegated assignments.
SGS is a leading life sciences CRO providing clinical research and bioanalytical testing with a specific focus on early stage development and biometrics. Delivering solutions in Europe and in Americas, SGS offers clinical trial (Phase I to IV) services encompassing full early phase drug development consultancy, clinical project management and monitoring, biometrics, PK/PD modeling & simulation and regulatory & medical affairs services. SGS has its own clinical unit in Belgium including a viral challenge testing facility and two phase I patient units based in Belgium and Hungary.
Sirris is the collective centre for and by the technological industry. We are a non-profit organisation that helps companies by focussing on your markets and technologies to facilitate the attainment of your objectives.
We offer individual support at every step along the way, from the drawing board stage right through to prototype development and pilot tests for finished products. In particular, Sirris has been developing for several years an engineering support activity for the healthcare sector. Its objective is to help any company or R&D actor to develop new devices or processes on a custom basis. Whether it is to miniaturize a new lab-on-a-chip, to customize an existing device for a given application or to realize a new surgical tooling, Sirris is your engineering partner. We leverage a large portfolio of world-class technologies available in-house: microfabrication, advanced manufacturing technologies by subtractive or additive approaches, polymer processing, printed electronics, mechatronics and data managemen.
Skymab Biotherapeutics is a CEA* spin-off biotech company committed to the design, engineering and development of antibodies targeting G Protein Coupled Receptors (GPCR) with a main focus in oncology.
Skymab was founded by enthusiastic scientists and entrepreneurs, thrilled to combine the most valuable technical knowledge in antibody discovery with their challenging know how in GPCR to create innovative tailored antibodies that achieved specific therapeutic strategies.
* French Atomic Agency (CEA), the most innovative public research organization in Europe according to a REUTERS ranking.
Spectralys Biotech offers innovative FTIR-based analytical solutions for chemicals, pharmaceuticals and biologics.
Spentys has developed a 3D platform allowing Certified orthotists & prosthetists to digitize their production processes through the use of 3D technologies; scanning, modeling and 3D printing
SRIW develops a wide range of tailored financing solutions to support all types of project: business creation, development through innovation or investment, organic growth requiring an increase in working capital, acquisitions, establishment of a subsidiary in Wallonia, Belgium or abroad, new markets, transfers and so on.
Stellaris Therapeutics is passionately committed to pioneering an emerging and promising therapeutic approach with the potential to effectively reverse established fibrosis across various tissues and diseases. Stellaris has its roots in the globally recognized academic environments of UCLouvain and KU Leuven.
Sterigenics is the global leader in comprehensive sterilization solutions serving customers across the medical device, pharmaceutical, commercial, and food industries.
SYnAbs SA, « Singular Antibodies », is one-stop-shop CRO, generating and manufacturing innovative monoclonal antibodies for In Vitro Diagnostic and Biopharmaceutical R&D applications. Thanks to unique proprietary technologies, SYnAbs can develop rat and guinea pigs mAbs of extreme specificity and higher affinity.
Centre de compétence qui a pour mission d’assurer des actions de formation et de sensibilisation aux différentes technologies présentent dans l’industrie.
Basé en Wallonie (Gosselies, Mons & Strépy).
TEXERE Biotech is bringing innovative technology solution for the processing of human tissue, in particular for the production of bone allograft
The ButterFly Fund is a pre-seed fund bridging the gap between R&D grants and seed rounds, co-created by Life Science Research Partners, Sambrinvest and Theodorus with the objective of supporting the transformation of disruptive science into innovative companies much earlier.
Theodorus is the spin-off fund of Université Libre de Bruxelles. The first Theodorus fund was created in 2003 as a result of ULB willingness to dedicate specific resources (funding and human resources) to its spin-offs. Since then, every Theodorus Investment Funds created have had the same priority access to ULB R&D outcomes and spin-offs.
Theodorus funds II & III were created in 2006 and 2013 with a priority access to ULB R&D outcomes and spin-offs.
TheraVet S.A. is a Walloon biotech company, created in November 2017 which develops innovative treatments for high unmet medical need osteoarticular conditions (e.g., joint, tendon/ligament and bone) for small companion animals such as dogs.
TheraVet's mature product portfolio is composed of biological as well as synthetic products developed from clinical stage and marketed human products.
Tiamat is developing a plant molecular farming technology to manufacture affordable growth factors and other proteins that will make cell-based meats a mainstream alternative. Our unique technology allows us superior flexibility with an affrodable production system and a scale-up potential up to the clean-meat requirements.
ULB, Université Libre de Bruxelles
Univercells is a technology company offering novel biomanufacturing platforms, aimed at increasing the availability and affordability of biologics – recombinant proteins and vaccines – for all. Univercells designs innovative production processes to significantly decrease the size of the necessary equipment and facility, for a lower capital and operational cost.
The hospital contains adult and child care services, as well as a polyclinic. It is above all the Centre for Reproductive Medicine (Centrum voor Reproductieve Geneeskunde) which is internationally recognised for its pioneering role in reproductive techniques. The hospital's emergency department is considered to be the largest emergency department in Flanders.
Unizima is a Belgian mission-oriented biotechnology company, affiliate of Univercells SA, working to make patient care accessible in low- and middle-income countries (LMICs) by facilitating the turnkey transfer of dedicated bioproduction capabilities combined with specialised care centres.
Unizima is patient-centric and will leverage the unique process development expertise and technology portfolio of Univercells group to design, build, maintain and operate (DBMO) specialised care centres with dedicated bioproduction. The uniqueness of Unizima lies in the structures and know-how to combine operational and technology transfer expertise with care centres to enable delivery of safe and effective products for patients. This business model represents a new paradigm for care in LMICs.
VIRIDAXIS is a Belgian company specialized in mass production of parasitoids to control aphids in a natural way. It uses an innovative, plant-less technology to guarantee products of constantly high quality. VIRIDAXIS was formed in 2004 and now employs around 45 people. Large investments are made in R&D, where the focus is on practical, reliable pest control products. The main goal is to make agriculture more sustainable.
Our customers are mostly internationally and nationally operating companies active in the field of biological pest control.
The Wallonia Export-Investment Agency (AWEX) is a Public Interest Organisation in Wallonia. It is the complete partner for all Walloon companies wishing to develop overseas and constitutes a one-stop shop for all foreign companies interested in setting up in Wallonia or expanding their existing activities.
XOMEXBIO is an affiliated company of convEyXO, building a specialized exosome platform and therapeutic portfolio. XomeXBio ensures engineering of exosomes as natural drug delivery system for therapeutics, applying microfluidic nano-technology to enable drug substance’ channeled loading.